Clinical practice guidelines for gastric cancer in Korea: An evidence-based approach
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, J.H. | - |
dc.contributor.author | Kim, J.G. | - |
dc.contributor.author | Jung, H.-K. | - |
dc.contributor.author | Kim, J.H. | - |
dc.contributor.author | Jeong, W.K. | - |
dc.contributor.author | Jeon, T.J. | - |
dc.contributor.author | Kim, J.M. | - |
dc.contributor.author | Kim, Y.I. | - |
dc.contributor.author | Ryu, K.W. | - |
dc.contributor.author | Kong, S.-H. | - |
dc.contributor.author | Kim, H.-I. | - |
dc.contributor.author | Jung, H.-Y. | - |
dc.contributor.author | Kim, Y.S. | - |
dc.contributor.author | Zang, D.Y. | - |
dc.contributor.author | Cho, J.Y. | - |
dc.contributor.author | Park, J.O. | - |
dc.contributor.author | Lim, D.H. | - |
dc.contributor.author | Jung, E.S. | - |
dc.contributor.author | Ahn, H.S. | - |
dc.contributor.author | Kim, H.J. | - |
dc.date.accessioned | 2021-09-05T16:05:34Z | - |
dc.date.available | 2021-09-05T16:05:34Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 2093-582X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/100782 | - |
dc.description.abstract | Although gastric cancer is quite common in Korea, the treatment outcome is relatively favorable compared to those in western countries. However, there are currently no Korean multidisciplinary guidelines for gastric cancer. Experts from related societies developed guidelines de novo to meet Korean circumstances and requirements, including 23 recommendation statements for diagnosis (n=9) and treatment (n=14) based on relevant key questions. The quality of the evidence was rated according to the GRADE evidence evaluation framework: the evidence levels were based on a systematic review of the literature, and the recommendation grades were classified as either strong or weak. The applicability of the guidelines was considered to meet patients' view and preferences in the context of Korea. The topics of the guidelines cover diagnostic modalities (endoscopy, endoscopic ultrasound, and radiologic diagnosis), treatment modalities (surgery, therapeutic endoscopy, chemotherapy, and radiotherapy), and pathologic evaluation. An external review of the guidelines was conducted during the finalization phase. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Gastric Cancer Association | - |
dc.subject | bevacizumab | - |
dc.subject | biochemical marker | - |
dc.subject | capecitabine | - |
dc.subject | cetuximab | - |
dc.subject | cisplatin | - |
dc.subject | docetaxel | - |
dc.subject | doxorubicin | - |
dc.subject | epirubicin | - |
dc.subject | fluorodeoxyglucose f 18 | - |
dc.subject | fluoropyrimidine | - |
dc.subject | fluorouracil | - |
dc.subject | gimeracil plus oteracil potassium plus tegafur | - |
dc.subject | irinotecan | - |
dc.subject | lapatinib | - |
dc.subject | oxaliplatin | - |
dc.subject | paclitaxel | - |
dc.subject | trastuzumab | - |
dc.subject | article | - |
dc.subject | cancer adjuvant therapy | - |
dc.subject | cancer palliative therapy | - |
dc.subject | cancer prognosis | - |
dc.subject | cancer recurrence | - |
dc.subject | cancer staging | - |
dc.subject | chromoendoscopy | - |
dc.subject | computer assisted tomography | - |
dc.subject | endoscopic echography | - |
dc.subject | endoscopic therapy | - |
dc.subject | gastrectomy | - |
dc.subject | gastrointestinal endoscopy | - |
dc.subject | gastroscopy | - |
dc.subject | human | - |
dc.subject | laparoscopic surgery | - |
dc.subject | lymph node dissection | - |
dc.subject | lymph node metastasis | - |
dc.subject | meta analysis (topic) | - |
dc.subject | nuclear magnetic resonance imaging | - |
dc.subject | phase 2 clinical trial (topic) | - |
dc.subject | phase 3 clinical trial (topic) | - |
dc.subject | positron emission tomography | - |
dc.subject | practice guideline | - |
dc.subject | randomized controlled trial (topic) | - |
dc.subject | stomach cancer | - |
dc.subject | survival rate | - |
dc.title | Clinical practice guidelines for gastric cancer in Korea: An evidence-based approach | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, H.J. | - |
dc.identifier.doi | 10.5230/jgc.2014.14.2.87 | - |
dc.identifier.scopusid | 2-s2.0-84903937482 | - |
dc.identifier.bibliographicCitation | Journal of Gastric Cancer, v.14, no.2, pp.87 - 104 | - |
dc.relation.isPartOf | Journal of Gastric Cancer | - |
dc.citation.title | Journal of Gastric Cancer | - |
dc.citation.volume | 14 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 87 | - |
dc.citation.endPage | 104 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001892259 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | bevacizumab | - |
dc.subject.keywordPlus | biochemical marker | - |
dc.subject.keywordPlus | capecitabine | - |
dc.subject.keywordPlus | cetuximab | - |
dc.subject.keywordPlus | cisplatin | - |
dc.subject.keywordPlus | docetaxel | - |
dc.subject.keywordPlus | doxorubicin | - |
dc.subject.keywordPlus | epirubicin | - |
dc.subject.keywordPlus | fluorodeoxyglucose f 18 | - |
dc.subject.keywordPlus | fluoropyrimidine | - |
dc.subject.keywordPlus | fluorouracil | - |
dc.subject.keywordPlus | gimeracil plus oteracil potassium plus tegafur | - |
dc.subject.keywordPlus | irinotecan | - |
dc.subject.keywordPlus | lapatinib | - |
dc.subject.keywordPlus | oxaliplatin | - |
dc.subject.keywordPlus | paclitaxel | - |
dc.subject.keywordPlus | trastuzumab | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | cancer adjuvant therapy | - |
dc.subject.keywordPlus | cancer palliative therapy | - |
dc.subject.keywordPlus | cancer prognosis | - |
dc.subject.keywordPlus | cancer recurrence | - |
dc.subject.keywordPlus | cancer staging | - |
dc.subject.keywordPlus | chromoendoscopy | - |
dc.subject.keywordPlus | computer assisted tomography | - |
dc.subject.keywordPlus | endoscopic echography | - |
dc.subject.keywordPlus | endoscopic therapy | - |
dc.subject.keywordPlus | gastrectomy | - |
dc.subject.keywordPlus | gastrointestinal endoscopy | - |
dc.subject.keywordPlus | gastroscopy | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | laparoscopic surgery | - |
dc.subject.keywordPlus | lymph node dissection | - |
dc.subject.keywordPlus | lymph node metastasis | - |
dc.subject.keywordPlus | meta analysis (topic) | - |
dc.subject.keywordPlus | nuclear magnetic resonance imaging | - |
dc.subject.keywordPlus | phase 2 clinical trial (topic) | - |
dc.subject.keywordPlus | phase 3 clinical trial (topic) | - |
dc.subject.keywordPlus | positron emission tomography | - |
dc.subject.keywordPlus | practice guideline | - |
dc.subject.keywordPlus | randomized controlled trial (topic) | - |
dc.subject.keywordPlus | stomach cancer | - |
dc.subject.keywordPlus | survival rate | - |
dc.subject.keywordAuthor | Guidelines | - |
dc.subject.keywordAuthor | Multidisciplinary | - |
dc.subject.keywordAuthor | Stomach neoplasms | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.